Boditech Media - Boditech Med

PRESS RELEASE

Boditech Med, Obtains Export Permit for the Biomarker 'PenKid' for Acute Kidney Injury Diagnosis

Obtained an Export Permit for PenKid, which enables a rapid diagnosis of acute kidney injury within 15 minutes

PRESS RELEASE

Boditech Med and Joinstar, Agreement for Chronic Disease Diagnosis in China

Joinstar will be supplied with key components of cartridges used in chronic disease diagnosis.

PRESS RELEASE

Boditech Med has obtained the export license of COVID-19 Ag Saliva rapid test kit

With a simple and safe sample collection, it can detect COVID-19 antigen in 15 minutes

PRESS RELEASE Boditech Med Receives ANVISA Approval for Four Diagnostic Kits for Dengue Fever and Latent TB
Products classified as Class III high-risk medical devices; approved following local clinical performance evaluations
PRESS RELEASE Boditech Med Holds Completion Ceremony for New Manufacturing Plant in India
New factory established in Jhajjar, India to enhance price competitiveness through local production
PRESS RELEASE Boditech Med Showcases Innovative IVD Solutions at CACLP 2025 in China
Cardiovascular and acute chest pain diagnostic panel, featuring ST2 & NT-proBNP, draws significant attention
PRESS RELEASE Boditech Med Receives Approval for Seven AFIAS Diagnostic Kits from Russia’s Health Authority
Certification completed for seven AFIAS kits: four for cardiovascular diseases and three for inflammatory markers
PRESS RELEASE Boditech Med Reports 2024 Revenue of $103.8 Million (138.1 Billion KRW), Up 2.9% Year-on-Year
Strong sales growth maintained across key regions, including Europe, Asia, the Middle East, and Africa.
PRESS RELEASE Boditech Med Signs MOU with China’s Autobio for Joint Development and Sales Collaboration
Comprehensive partnership established to jointly develop core products and expand sales.
PRESS RELEASE Boditech Med Completes CE-IVDR Certification for 14 Diagnostic Devices and 142 Diagnostic Kits
Products verified to meet increasingly stringent global certification standards
PRESS RELEASE Boditech Med Reports Record Sales of 28.08 million USD in Q3 2024, Highest Since COVID-19 Endemic
Consolidated revenue for Q3 2024 recorded at 28.08 million USD (37.6 billion KRW), with an operating profit of 6.57 million USD (8.8 billion KRW).
PRESS RELEASE Boditech Med Reports Operating Profit of 7.15 Million USD in Q2 2024, Up 13% Year-on-Year
Sales reached 27.85 million USD (36.2 billion KRW) with an operating profit of 7.15 million USD (9.3 billion KRW) in Q2 2024
PRESS RELEASE Boditech Med Signs MOU with Taiwan's BPM for Diabetic Kidney Disease Prediction Marker
MOU signed for the license of diabetic kidney disease prediction marker 'DNlite-IVD103'.

1 2 3 4 5

Smart Guide